肌钙蛋白I升高与心脏不停跳冠状动脉手术患者长期预后较差相关
该研究纳入996例择期行单纯冠状动脉旁路移植术(CABG)的稳定或不稳定心绞痛患者,按术后峰值肌钙蛋白I(ppTnI)第80百分位数分为高、低两组。结果显示,心脏不停跳CABG亚组中ppTnI≥3.3 ng/ml者10年总生存率显著低于<3.3 ng/ml者(64% vs 73%,P=0.010),而常规CABG亚组无显著差异;多变量分析显示,心脏不停跳CABG中ppTnI超过第80百分位数是总死亡的独立危险因素(HR 1.505,95%CI 1.019-2.225,P=0.040)。
要点
- 心脏不停跳CABG亚组中,ppTnI≥3.3 ng/ml者10年总生存率显著低于<3.3 ng/ml者(64% vs 73%,P=0.010)。
- 常规CABG亚组中,ppTnI≥8.9 ng/ml与<8.9 ng/ml两组10年总生存率无显著差异(71% vs 76%,P=0.316)。
- 心脏不停跳CABG中,ppTnI超过第80百分位数是总死亡的独立危险因素(HR 1.505,95%CI 1.019-2.225,P=0.040)。
核心结论
- 在心脏不停跳CABG患者中,术后峰值肌钙蛋白I超过第80百分位数与较差的长期生存相关;在常规CABG患者中未观察到这一关联。
研究设计与样本
- 研究纳入996例因稳定或不稳定心绞痛行择期单纯CABG的患者,按术后峰值肌钙蛋白I(ppTnI)第80百分位数分为高、低两组,分析ppTnI与长期临床结局的关系。
主要发现
- 总体ppTnI中位数为1.55(2.74)ng/ml;常规CABG亚组为4.04(4.71)ng/ml,显著高于心脏不停跳CABG亚组的1.24(1.99)ng/ml(P < 0.001)。
- 心脏不停跳CABG亚组ppTnI第80百分位数为3.3 ng/ml,常规CABG亚组为8.9 ng/ml。
- 常规CABG亚组(n = 150)中,ppTnI高组(≥8.9 ng/ml)与低组(<8.9 ng/ml)10年总生存率分别为71%(10%)和76%(5%),无显著差异(P = 0.316)。
- 心脏不停跳CABG亚组(n = 846)中,ppTnI高组(≥3.3 ng/ml)10年总生存率显著低于低组(<3.3 ng/ml):64%(6%)vs 73%(3%),P = 0.010。
- 心脏不停跳CABG亚组多变量分析显示,ppTnI超过第80百分位数是总死亡的危险因素(HR 1.505,95%CI 1.019-2.225,P = 0.040)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The impacts of elevated troponin I levels after coronary artery bypass grafting (CABG) on long-term outcomes were investigated. METHODS: A total of 996 patients who underwent elective isolated CABG for stable or unstable angina were enrolled. Patients were divided into higher and lower groups based on 80th percentile postoperative peak troponin I (ppTnI) levels. The relationship between ppTnI and long-term clinical outcomes was analysed. RESULTS: The median ppTnI was 1.55 (2.74) ng/ml and was significantly higher in the conventional CABG subgroup than in the beating-heart CABG subgroup: 4.04 (4.71) vs 1.24 (1.99) ng/ml, P < 0.001. The 80th percentile of ppTnI was 3.3 ng/ml in the beating-heart CABG subgroup and 8.9 ng/ml in the conventional CABG subgroup. In the conventional CABG subgroup (n = 150), 10-year overall survival showed no significant difference between the higher (≥8.9 ng/ml) and lower (<8.9 ng/ml) ppTnI groups: 71% (10%) vs 76% (5%), P = 0.316. However, the beating-heart CABG subgroup (n = 846) showed significantly worse 10-year overall survival in the higher ppTnI group (≥3.3 ng/ml) than in the lower ppTnI group (<3.3 ng/ml): 64% (6%) vs 73% (3%), P = 0.010. In the beating-heart CABG subgroup, multivariable analysis showed that ppTnI exceeding the 80th percentile was a risk factor for overall death (hazard ratio: 1.505, 95% confidence interval: 1.019-2.225, P = 0.040). CONCLUSIONS: Higher ppTnI over the 80th percentile was associated with worse long-term survival in beating-heart CABG, but not in conventional CABG.
引用
- Kim KM, Kim SY, Jung JC, et al. Elevated troponin I is associated with a worse long-term prognosis in patients undergoing beating-heart coronary surgery. Eur J Cardiothorac Surg. 2023. PMID: 36946289. doi:10.1093/ejcts/ezad087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。